Presentation THT 2026 Case Resolution Presenter: Matthew Lawlor March 02, 2026 REGISTER for free or LOG IN to view this content THT 2026 Up Next Presentation THT 2026 Autologous Cell Therapy May Curb Pathological Ventricular Remodeling in Chronic Ischemic HFrEF Patients Selected for Favorable Cell Characteristics - Late Breaking Echocardiography Results from the CardiAMP HF trial Presenter: Amish Raval March 02, 2026 More slides + Presentation THT 2026 Initial Six-Month Outcomes With Baroreflex Activation Therapy From the REBALANCE Registry Presenter: Dmitry Yaranov March 02, 2026 Presentation THT 2026 Prospective Validation of the STOPSHOCK Score for Early Cardiogenic Shock Prediction in Acute Coronary Syndrome: A Real-World Perspective Presenter: Allan Böhm March 02, 2026 We Recommend Disclosures <p>Nothing to disclose</p>
Presentation THT 2026 Autologous Cell Therapy May Curb Pathological Ventricular Remodeling in Chronic Ischemic HFrEF Patients Selected for Favorable Cell Characteristics - Late Breaking Echocardiography Results from the CardiAMP HF trial Presenter: Amish Raval March 02, 2026
Presentation THT 2026 Initial Six-Month Outcomes With Baroreflex Activation Therapy From the REBALANCE Registry Presenter: Dmitry Yaranov March 02, 2026
Presentation THT 2026 Prospective Validation of the STOPSHOCK Score for Early Cardiogenic Shock Prediction in Acute Coronary Syndrome: A Real-World Perspective Presenter: Allan Böhm March 02, 2026